Idera Pharmaceuticals, Inc.

Formerly Hybridon, Idera Pharmaceuticals is developing treatments for disease that modulate immune responses through toll-like receptors. Fassino/Design worked with the company on the new name, designed a corporate identity that reflected their science as well as the concept of ideas.